Climb Bio (CLYM) Exchange Rate Effect (2020 - 2025)
Climb Bio (CLYM) reported Exchange Rate Effect of $24000.0 for Q2 2025, up 26.32% on a YoY basis from $19000.0 in Q2 2024, and up 200.0% quarter-over-quarter from -$24000.0 in Q1 2025.
Climb Bio (CLYM) Exchange Rate Effect (2020 - 2025) Analysis & Trends
Climb Bio has reported Exchange Rate Effect for 6 years, with the latest figure at $24000.0 in Q2 2025.
- For the quarter ending Q2 2025, Exchange Rate Effect rose 26.32% year-over-year to $24000.0; the trailing twelve-month figure through Mar 2026 stood at $24000.0 (down 47.83% YoY), and the FY2024 full-year result was $42000.0, down 86.18% from the prior year.
- Exchange Rate Effect for Q2 2025 stood at $24000.0, up from -$24000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $1.8 million in Q4 2022, with the low at -$1.1 million in Q2 2022.
- Historically, Exchange Rate Effect has averaged $10764.7 across 5 years, with a median of $19000.0 in 2024.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect slumped 1355.7% — and 2024, when it surged 2600.0%.
- Climb Bio's Exchange Rate Effect stood at $79000.0 in 2021, then surged by 2193.67% to $1.8 million in 2022, then sank by 118.21% to -$330000.0 in 2023, then jumped by 82.73% to -$57000.0 in 2024, then soared by 142.11% to $24000.0 in 2025.
- The last three Exchange Rate Effect figures came in at $24000.0 (Q2 2025), -$24000.0 (Q1 2025), and -$57000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 8.68 Mn |
| 10 | Climb Bio | 740.73 Mn | 740.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 24,000.00 |
| Jun 30, 2025 | 24,000.00 |
| Mar 31, 2025 | -24,000.00 |
| Mar 31, 2025 | -24,000.00 |
| Dec 31, 2024 | -57,000.00 |
| Dec 31, 2024 | -57,000.00 |
| Sep 30, 2024 | 108,000.00 |
| Sep 30, 2024 | 108,000.00 |
| Jun 30, 2024 | 19,000.00 |
| Jun 30, 2024 | 19,000.00 |
| Mar 31, 2024 | -28,000.00 |
| Mar 31, 2024 | -28,000.00 |
| Dec 31, 2023 | -330,000.00 |
| Dec 31, 2023 | -330,000.00 |
| Sep 30, 2023 | 4,000.00 |
| Sep 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 399,000.00 |
| Jun 30, 2023 | 399,000.00 |
| Mar 31, 2023 | 231,000.00 |
| Mar 31, 2023 | 231,000.00 |